Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Erez Levanon lab, |
RCV000225020 | SCV000282021 | pathogenic | Atrophia bulborum hereditaria | 2016-05-01 | criteria provided, single submitter | research | |
Erez Levanon lab, |
RCV000225062 | SCV000282022 | pathogenic | Exudative vitreoretinopathy 5 | 2016-05-01 | criteria provided, single submitter | research | |
Erez Levanon lab, |
RCV000225079 | SCV000282023 | pathogenic | Persistent hyperplastic primary vitreous, autosomal recessive | 2016-05-01 | criteria provided, single submitter | research | |
Gene |
RCV003328570 | SCV004035660 | pathogenic | not provided | 2023-05-16 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25250762, 26306921, 30452590, 31456290) |
Institute for Medical Genetics and Human Genetics, |
RCV000225062 | SCV005380248 | pathogenic | Exudative vitreoretinopathy 5 | criteria provided, single submitter | not provided | ||
Sharon lab, |
RCV001003234 | SCV001161313 | likely pathogenic | Familial exudative vitreoretinopathy | 2019-06-23 | no assertion criteria provided | research |